Ascorbic acid 100mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Ascorbic acid

Available from:

Kent Pharma (UK) Ltd

ATC code:

A11GA01

INN (International Name):

Ascorbic acid

Dosage:

100mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 09060301; GTIN: 5015201009535

Patient Information leaflet

fold 35 mm
fold 35 mm
280 mm
150 mm
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
Always take this medicine exactly as described in this leaflet or as
your doctor or pharmacist has told you.
• KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN.
• ASK YOUR PHARMACIST IF YOU NEED MORE INFORMATION OR ADVICE. IF YOU
GET ANY SIDE EFFECTS, TALK
TO YOUR DOCTOR OR PHARMACIST. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS
NOT LISTED IN THIS LEAFLET.
SEE SECTION 4.
• YOU MUST TALK TO A DOCTOR IF YOU DO NOT FEEL BETTER OR IF YOU FEEL
WORSE. WHAT IS IN THIS LEAFLET
1. What Vodexo
®
is and what it is used for
2. What you need to know before you take Vodexo
®
3. How to take Vodexo
®
4. Possible side effects
5. How to store Vodexo
®
6. Contents of the pack and other information
WHAT VODEXO
® IS AND WHAT IT IS
Vodexo
®
Tablets belong to a group of medicines
called vitamins. Ascorbic acid is also known as
Vitamin C. Vodexo
®
Tablets are used for the
treatment of Vitamin C deficiency. They are
also used to treat scurvy (a serious condition
due to a long-term lack of dietary Vitamin C). WHAT YOU NEED TO KNOW BEFORE YOU TAKE VODEXO
®
DO NOT TAKE VODEXO
®
:
•
if you are allergic to ascorbic acid or any
of the other ingredients of this medicine
(listed in section 6)
•
if you suffer from hyperoxaluria (excretion
of urine containing large amounts of
calcium oxalate crystals)
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking
Vodexo
®
if you:
•
are to undergo any blood or urine tests
as ascorbic acid can interfere with some
blood and urine tests
•
are a regular smoker
•
have kidney failure as ascorbic acid
enhances aluminium absorption (present
in antacids) which may reach toxic levels.
OTHER MEDICINES AND VODEXO
®
Tell your doctor or pharmacist if you are
taking, have recently taken or might take
any other medicines.
Vodexo
®
Tablets may interfere with other
medicines that you may be taking.
This includes medicines you

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ascorbic Acid 100mg Tablets
Vodexo 100mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100mg ascorbic acid
Excipients with known effect: contains 0.60 mg/tablet lactose
monohydrate
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
White to off-white uncoated tablets.
Ascorbic Acid 100mg Tablets are 8 mm, white to off-white, plain,
round,
biconvex tablets.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Vitamin C deficiency
Treatment of scurvy
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults: _
Therapeutic use – at least 250mg daily in divided doses._ _
Maximum of 1000mg daily.
_Elderly: _
As for other adults. As the dietary intake of vitamin C may be
less in the elderly, they have greater risk of presenting with vitamin
C
deficiency.
Method of administration
For oral administration.
4.3
CONTRAINDICATIONS
Ascorbic acid should not be given to patients with hyperoxaluria.
Hypersensitivity to the active substance or to any of the excipients
listed in section
6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Increased intake of ascorbic acid over a prolonged period may result
in increased
renal clearance of ascorbic acid, and deficiency may result if the
intake is reduced
or withdrawn rapidly. (See section 4.8)
INTERFERENCE WITH SEROLOGICAL TESTING
Ascorbic acid may interfere with tests and assays for urinary glucose,
giving false-
negative results with methods utilising glucose oxidase with indicator
(e.g. Labstix,
Testape) and false- positive results with neocuproin methods.
Estimation of uric acid by phosphotungstate or uricase with copper
reduction and
measurement of creatinine in non-deproteinised serum may also be
affected.
High doses of ascorbic acid may give false-negative readings in faecal
occult blood tests.
This product contains lactose. Patients with rare hereditary problems
of galactose intolerance,
the Lapp lactase deficiency or glucose-galactose malabsorption should
not take